Sh-control CDC-treated animals displayed superior global function, attenuation of adverse remodeling, and increased capillary density compared to sh-SDF1 CDC-treated animals 5 weeks post-MI, while both CDC-treated groups outperformed the infarcted controls (Fig 8F, Supplementary Figs S9 and S10). Here, CXCL12 is linked to myocardial infarction.